financing

IM Cannabis ($IMCC) closes convertible note financing totaling $550,000 in gross proceeds to support general corporate purposes.

GameStop's $55.5 billion eBay acquisition relies on TD Securities' non-binding letter rather than committed financing, creating significant execution risk.

GameStop offers $125/share for eBay in $55.5B deal, leveraging retail footprint to transform into $100B+ commerce powerhouse under Ryan Cohen's leadership.

Diana Shipping launches $23.50/share hostile bid for Genco, offering 31% premium with $1.433B committed financing and board slate.

Altimmune closed a $225M oversubscribed public offering led by Deep Track Capital. Proceeds will fund Phase 3 MASH trial initiation in H2 2026 and operational runway through data readout.

Blue Moon Metals closes C$4.8M financing from Hartree Partners to develop five brownfield polymetallic projects, subject to TSX Venture Exchange approval.

Giga Metals raises C$1M via private placement at C$0.08/unit for Turnagain nickel-cobalt project in British Columbia, with closing expected May 2026.

Over 1,000 Hollywood creators urge regulators to block Paramount-Warner Bros merger, citing consolidation fears, while Paramount secures permanent financing reducing debt by $5 billion.

Sun Pharma finalizes $12B binding offer for Organon, marking India's largest overseas pharma acquisition amid industry consolidation.

Paramount Skydance secures $10 billion permanent financing for Warner Bros. Discovery acquisition, reducing total debt commitment to $49 billion with closing targeted for July 2026.

Vertical Aerospace secures $850M from Mudrick Capital and Yorkville Advisors, including $50M equity and $750M optional financing, shifting focus from survival to execution on eVTOL development.

Centerra Gold invests C$10M in Nevada King for 9.9% stake, funding Atlanta Gold Mine exploration in Nevada through C$16M private placement closing Q2 2026.

i-80 Gold closes $250M gold prepayment facility and completes $1B+ recapitalization, fully funding development through 2031 production targets.

Tenon Medical reports 92% Q4 revenue growth to $1.5M, achieves 69% gross margins, secures FDA clearance and $4.3M financing for spine fusion device expansion.

$CRIS reports $19.4M Q4 earnings from one-time Erivedge sale; refocuses on PCNSL and CLL studies with $20.2M PIPE funding.

NexGel acquires regenerative biomaterial portfolio from Celularity, expecting to nearly triple 2026 revenue to $35M and achieve immediate profitability.

Diana Shipping increases all-cash offer for Genco Shipping to $23.50/share, a 31% premium, with $1.433B in committed financing and Star Bulk's vessel purchase agreement.

Rallybio soars as merger with $505M-backed Candid Therapeutics creates combined biotech with $700M cash runway through 2030.

Juggernaut Exploration raises C$10M through flow-through private placement to fund exploration of its Big One Gold Project in British Columbia's Golden Triangle.

ContextLogic completes $907.5M acquisition of US Salt, pivoting from e-commerce to a business ownership platform model with new institutional investors.